These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20396921)

  • 1. Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation.
    Daoussis D; Panoulas VF; John H; Toms TE; Antonopoulos I; Treharne G; Nightingale P; Douglas KM; Kitas GD
    Clin Rheumatol; 2011 Apr; 30(4):477-84. PubMed ID: 20396921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.
    Toms TE; Panoulas VF; John H; Douglas KM; Kitas GD
    Arthritis Res Ther; 2009; 11(4):R110. PubMed ID: 19607680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis.
    Panoulas VF; Douglas KM; Milionis HJ; Stavropoulos-Kalinglou A; Nightingale P; Kita MD; Tselios AL; Metsios GS; Elisaf MS; Kitas GD
    Rheumatology (Oxford); 2007 Sep; 46(9):1477-82. PubMed ID: 17704521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microalbuminuria in patients with rheumatoid arthritis.
    Pedersen LM; Nordin H; Svensson B; Bliddal H
    Ann Rheum Dis; 1995 Mar; 54(3):189-92. PubMed ID: 7748016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases.
    Abourazzak FE; Mansouri S; Najdi A; Tahiri L; Nejjari C; Harzy T
    Clin Rheumatol; 2014 Nov; 33(11):1549-55. PubMed ID: 24647982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.
    Duruöz MT; Ataman Ş; Bodur H; Çay HF; Melikoğlu MA; Akgül Ö; Çapkın E; Gürer G; Çevik R; Göğüş FN; Kamanlı A; Yurdakul FG; Yağcı İ; Rezvani A; Altan L
    Rheumatol Int; 2024 Feb; 44(2):291-301. PubMed ID: 38157014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.
    Naranjo A; Sokka T; Descalzo MA; Calvo-Alén J; Hørslev-Petersen K; Luukkainen RK; Combe B; Burmester GR; Devlin J; Ferraccioli G; Morelli A; Hoekstra M; Majdan M; Sadkiewicz S; Belmonte M; Holmqvist AC; Choy E; Tunc R; Dimic A; Bergman M; Toloza S; Pincus T;
    Arthritis Res Ther; 2008; 10(2):R30. PubMed ID: 18325087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study.
    Dao HH; Do QT; Sakamoto J
    Arthritis Res Ther; 2010; 12(6):R218. PubMed ID: 21182767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study.
    Toms TE; Panoulas VF; Douglas KM; Griffiths HR; Kitas GD
    Arthritis Res Ther; 2008; 10(6):R145. PubMed ID: 19091101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microalbuminuria in rheumatoid arthritis].
    Nordin H; Pedersen LM; Svensson BH; Bliddal H
    Ugeskr Laeger; 1996 May; 158(22):3141-3. PubMed ID: 8686047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndrome.
    Burggraaf B; van Breukelen-van der Stoep DF; de Vries MA; Klop B; van Zeben J; van de Geijn GM; van der Meulen N; Birnie E; Prinzen L; Castro Cabezas M
    Atherosclerosis; 2018 Apr; 271():84-91. PubMed ID: 29482038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease.
    Crowson CS; Myasoedova E; Davis JM; Matteson EL; Roger VL; Therneau TM; Fitz-Gibbon P; Rodeheffer RJ; Gabriel SE
    J Rheumatol; 2011 Jan; 38(1):29-35. PubMed ID: 20952464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the association between metabolic syndrome and disease activity in rheumatoid arthritis.
    Sahebari M; Goshayeshi L; Mirfeizi Z; Rezaieyazdi Z; Hatef MR; Ghayour-Mobarhan M; Akhlaghi S; Sahebkar A; Ferns GA
    ScientificWorldJournal; 2011 Jun; 11():1195-205. PubMed ID: 21666989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metabolic syndrome in rheumatoid arthritis patients from Northeastern Brazil: Association with disease activity.
    Gomes KWP; Luz AJP; Felipe MRB; Beltrão LA; Sampaio AXC; Rodrigues CEM
    Mod Rheumatol; 2018 Mar; 28(2):258-263. PubMed ID: 28486047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome.
    Cioffi G; Viapiana O; Tarantini L; Orsolini G; Idolazzi L; Sonographer FO; Dalbeni A; Gatti D; Fassio A; Rossini M; Giollo A
    Intern Emerg Med; 2021 Jun; 16(4):863-874. PubMed ID: 33083946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microalbuminuria in patients with essential hypertension and its relationship to target organ damage: an Indian experience.
    Hitha B; Pappachan JM; Pillai HB; Sujathan P; Ramakrishna CD; Jayaprakash K; Raihanathul Misiriya KJ
    Saudi J Kidney Dis Transpl; 2008 May; 19(3):411-9. PubMed ID: 18445902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis.
    Liao KP; Solomon DH
    Rheumatology (Oxford); 2013 Jan; 52(1):45-52. PubMed ID: 22986289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of microalbuminuria with metabolic syndrome: a cross-sectional study in Bangladesh.
    Saadi MM; Roy MN; Haque R; Tania FA; Mahmood S; Ali N
    BMC Endocr Disord; 2020 Oct; 20(1):153. PubMed ID: 33028296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome in Algerian rheumatoid arthritis patients. Correlation with disease activity and functional status.
    Slimani S; Abbas A; Ben Ammar A; Rahal F; Khider I; Khelif K; Ladjouze-Rezig A
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S425-S427. PubMed ID: 28395950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current limitations in the management of cardiovascular risk in rheumatoid arthritis.
    Scott IC; Ibrahim F; Johnson D; Scott DL; Kingsley GH
    Clin Exp Rheumatol; 2012; 30(2):228-32. PubMed ID: 22325679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.